Mealey's PI/Product Liability - Del. Federal Judge Dismisses Infuse Off-Label Claims As Preempted By Federal Law

Mealey's PI/Product Liability - Del. Federal Judge Dismisses Infuse Off-Label Claims As Preempted By Federal Law

WILMINGTON, Del. - A Delaware federal judge on July 28 said a plaintiff's claims that Medtronic Inc. marketed its Infuse bone graft for off-label purposes are preempted by federal law (Eileen Scanlon v. Medtronic Sofamor Danek USA Inc., et al., No. 13-224, D. Del.; 2014 U.S. Dist. LEXIS 102387).

Find full version on lexis Advance®
Access this news story on lexis.com®